Industries > Pharma > Pharma Leader Series – Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024

Pharma Leader Series – Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024

PUBLISHED: 26 September 2014
PAGES: 330
PRODUCT CODE: PHA0008
SUBMARKET: Contract Services

Clear
WOOCS 2.2.1
SKU: PHA0008 Categories: ,

Contract manufacturing for pharma – discover top companies’ revenue prospects
How are pharma contract manufacturing organisations (CMOs) performing? Visiongain’s new report shows you their prospects to 2024. There you discover that industry and market’s results, trends, opportunities and prospects, also with predicted revenues and profits.

Our study analyses 30 top CMOs. There you see how revenues from drug production services can increase. So what trends, technologies and opportunities most shape the future? You find out, benefiting your knowledge, decisions and authority.

That way you discover analysis on established and emerging companies across the world. Read on, then, to scan those organisations and see what their future market could be worth.

Forecasts and other data to help you stay ahead for commercial data
In that updated study you find analytical profiles of 30 top companies, and analyses of their overall industry. You discover historical data, market and sales shares, growth rates and revenue forecasts. See, too, qualitative analyses, business outlooks and developments.

There you gain 184 tables, 111 charts and five interviews with that industry.

Our work lets you assess the most lucrative services in outsourced drug making. That way you can stay ahead in understanding the CMO industry and market. And also benefit your research, analyses and influence. In particular, see prospects for these market segments:
• Active pharmaceutical ingredients (API) production
• Finished dosage formulations (FDF) manufacturing.

There hear how you can benefit your work, also saving time and helping you stay ahead of competitors. And the following sections highlight what our updated investigation gives you.

Company profiles – activities, results, competition and prospects
Our report analyses 30 leading companies. The content of each profile differs, depending on the organisation. In general, though, a profile gives you the following information:
• Overview of the company’s contract manufacturing services, including clients
• Analysis of recent financial performance – annual revenue for CMO services, operating profit and margin
• Assessment of developments – activities, acquisitions, production capacity, deals, new service offerings and collaborations
• SWOT analysis – a firm’s strengths and weaknesses, as well as opportunities and threats to manufacturing sales growth from 2014 onwards
• Forecasting of pharmaceutical manufacturing revenue to 2024 (for 28 firms), as well as projected operating profit and margin for some companies
• Transcript of an interview by Visiongain (for five companies).

Discover there what participants offer, achieve, aim for and say, helping you stay ahead.

European contract manufacturing organisations
First our study gives you discussions, financial analyses and commercial outlooks for 14 European CMOs, including these firms:
• Lonza
• Evonik Degussa
• Royal DSM
• Boehringer Ingelheim
• Fareva
• Famar
• Vetter Pharma.

Discover what the future holds for those pharma service providers, including revenue outlooks to 2024. What profitability and other achievements are possible?

CMOs based in the US and Japan
Next our report shows you developments and business outlooks for seven other medical production contractors:
• Catalent Pharma Solutions
• Patheon
• Baxter BioPharma Solutions
• AbbVie Contract Manufacturing
• Pfizer CentreSource
• Daito Pharmaceutical
• Nipro Corporation.

Our work shows you where sales growth can occur. Many opportunities remain, with high, expanding revenues forecasted from 2014. You discover where prospects exist, seeing what’s possible.

Developed-market API specialists
You also discover outlooks for three top producers of active pharmaceutical ingredients:
• Teva API
• Esteve Química
• Euticals.

Our report shows you potentials of that industry. You see possibilities for advancing medical technology and raising business performance, with better serving of clients.

India and China – analysis of pharma manufacturing service providers
Our work also assesses six Indian and Chinese companies. There you discover activities and prospects of these firms:
• Dr. Reddy’s Laboratories
• Aurobindo Pharma
• Divis Laboratories
• Shandong Xinhua Pharmaceutical
• Zhejiang Hisun Pharmaceutical
• Zhejiang Huahai Pharmaceuticals.

That way you find sales data and underlying trends, seeing what the present and future hold.

Predictions for the worldwide pharma CMO market and submarkets
Our report also forecasts revenues to 2024 for the world contract manufacturing industry and its main segments: APIs and FDFs.

There you see overall world revenues reaching $71bn in 2018. Our analyses reveal high sales expansion from 2014 to 2024. That work also predicts large companies and specialty healthcare firms will develop and prosper. She why, how and where, finding potentials.

In particular, biologics and biosimilars hold promise. New therapies – including antibody-drug conjugates, high potency APIs and regenerative medicines – interest CMOs and clients.

So discover opportunities and revenue predictions for outsourced production of medicines. You investigate established and rising companies, finding their potentials.

Ways Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024 helps
In particular, our new investigation benefits your work through the following analyses:
• Revenues to 2024 for the world pharma contract manufacturing organisations (CMO) market – discover that industry’s prospects, finding promising segments for investments and revenues
• Profiles of 30 leading companies there – assess services, strategies, sales results and outlooks, also gaining revenue forecasts to 2024 for 28 of the firms, and with profit predictions for some
• Interviews with five top companies in the CMO industry – find debates and opinions, helping you stay ahead
• Competition and opportunities – see what affects that industry, exploring what shapes its future, esp. prospects for sustaining and developing business
• Analysis of what stimulates and restrains that industry and market – assess challenges and strengths, helping you compete and succeed.

Information there found nowhere else, helping you research, analyse and plan
That work gives independent analysis. There you get business intelligence found only in our report, seeing where prospects are most rewarding.

By choosing our study you’re less likely to fall behind in knowledge or miss opportunity. Discover there how you could benefit your research, analyses and decisions. Also see how you could save time and gain in recognition for technological and commercial insight.

Prospects for pharma manufacturing providers – try our new analysis now
Our new study gives you data, trends, opportunities and business predictions for outsourced drug and API production. Avoid missing out – instead please get our report here now.

Visiongain is a trading partner with the US Federal Government
CCR Ref number: KD4R6

Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series – Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024


Download sample pages

Complete the form below to download your free sample pages for Pharma Leader Series – Leading Pharmaceutical Contract Manufacturing Organisations (CMOs) 2014-2024


Latest Pharma news

Visiongain Publishes Clinical Trial Supplies Market Report 2021-2031

Deviating from protocols raises the danger of missing or delaying data collection from current investigations. This highlights the growing importance of digital medicine, which is being aided by advancements in cloud, mobile, and IoT technology.

11 October 2021

READ

Visiongain Publishes Drug Discovery Informatics Market Report 2021-2031

High performance HPC and supercomputing technology have evolved substantially in China in the last decades, leading to extraordinary accomplishments. HPC-based and combined pharmaceutical chemical and computational biology computational discovery and design has become a significant technique in drug research and development and is sponsored financially by the Chinese government.

07 October 2021

READ

Visiongain Publishes Pharma Wholesale and Distribution Market Report 2021-2031

Many health-care organizations are seeing organic growth at levels that their supply networks were never designed to handle. Others are frantically attempting to integrate diverse technology and procedures as part of a consolidation effort.

06 October 2021

READ

Visiongain Publishes Meningococcal Vaccines Market Report 2021-2031

Rise in prevalence of meningitis, increasing initiatives by government and regulatory authorities coupled strong funding support from non-profit organizations is expected to drive the global meningococcal vaccines market

05 October 2021

READ

Categories